Navigation Links
EUSA Pharma Out-Licenses Preclinical-Stage Human Antibody to GlaxoSmithKline for up to $44 Million Plus Royalties
Date:2/18/2008

lion company by the beginning of the next decade.

For more information please visit http://www.eusapharma.com.


'/>"/>
SOURCE EUSA Pharma Inc
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Anemia and tropical diseases; Is pharmacogenomics ready for the clinic?
2. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
3. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
4. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
5. The Pharma & Life Sciences Best Practice Database: an Industry Resource for Successful Techniques and Performance Benchmarks for Reaching the Top
6. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
8. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
9. AKELA Pharma Inc. announces positive results for the extension part of its Phase IIb Fentanyl TAIFUN(R) trial
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
11. Innocoll Agrees the Sale of its CollaRx(R) GENTAMICIN SURGICAL IMPLANT and European Sales and Marketing Infrastructure to EUSA Pharma

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...e-USNewswire/ -- The American Academy of Physician...clinically practicing physician assistants (PAs) p...House of Representatives for passing Saturday its ... Health Care for America Act. ,, "We are especi...ly lower the cost of health care and greatly expan...
(Date:11/9/2009)...ital and the University of Florida Proton Therapy ...roton therapy for St. Jude patients. The announcem...dy to evaluate the use of proton therapy for rare .... , Under the clinical protocol, St. Jude will...F Proton Therapy Institute in Jacksonville, Fla. T...
(Date:11/9/2009)...hire plc (LSE: SHP, NASDAQ: SHPGY), the global spe...the availability of INTUNIV (guanfacine) Extended ...ates for the treatment of Attention-Deficit/Hypera...s ages 6 to 17. INTUNIV, a once-daily formulation... alpha-2A receptor agonist approved for the treatm...
(Date:11/9/2009)... first human embryonic stem cell treatment approve...estore limb function in rats with neck spinal cord...l trial to include people with cervical damage. ,...gave Geron Corp. of Menlo Park, Calif., permission...th thoracic spinal cord injuries, which occur belo...
(Date:11/9/2009)...ight be the reason why African Americans are not r...ate as similar patients in other racial groups. D... transplantation at Georgetown University Hospital...University Medical Center, and colleagues explore ...ican Journal of Transplantation . , Medicare co...
Breaking Medicine News(10 mins):Health News:American Academy of Physician Assistants Applauds U.S. House of Representatives for Passing Health Care Reform Bill 2Health News:St. Jude and UF Proton Therapy Institute to begin proton therapy clinical trial 2Health News:Once-daily INTUNIV (guanfacine) extended release tablets now available in US pharmacies 2Health News:Once-daily INTUNIV (guanfacine) extended release tablets now available in US pharmacies 3Health News:Once-daily INTUNIV (guanfacine) extended release tablets now available in US pharmacies 4Health News:UCI embryonic stem cell therapy restores walking ability in rats with neck injuries 2Health News:Physician bias might keep life-saving transplants from black and Hispanic patients 2
...C., Oct. 25 PhoneTree(R) is unveiling,PhoneTree P...nt Association,(MGMA) 2007 Annual Conference, Octo...tions beginning at $99 per month, PhoneTree Patien...ective patient communication with prompt return on...
...ct. 25 The U.S. Department,of Health and Human Se...,today released Adapting Community Call Centers fo... Monitoring, a new report that recommends expandin...public shelters in the event of public health emer...
...e to Have Disproportionate Impact On Latinos, Othe...s, OAKLAND, Calif., Oct. 25 Sutter Health,s plan...o will have a particularly,adverse impact on the c...NOC presented the data at a San Francisco press,co...
... of Rochester Medical Center (URMC) announced toda...w York developer and philanthropist Richard T. Fie... the largest private donation for a specific dise...of muscular dystrophy. , The new Fields Center fo...
...tion of beta-amyloid clumps in mice, study says , ...e blood pressure drug valsartan shows the ability ...e, researchers report. , The potential value of va...etti, a professor of psychiatry and neurosciences ...
...5 /PRNewswire-FirstCall/ - SXC Health Solutions In...ordon S. Glenn, Chairman and,Chief Executive Offic...ber,8, 2007 at 8:30 a.m. ET to discuss the Company...terested parties can join the call by dialing 416-...
Other Medicine News:Health News:AHRQ Report Recommends Use of Existing Call Centers to Expand Communications in Public Health Emergencies 2Health News:CNA Presents New Data on Sutter's Medical Redlining 2Health News:CNA Presents New Data on Sutter's Medical Redlining 3Health News:New center to lead international muscular dystrophy research effort 2Health News:New center to lead international muscular dystrophy research effort 3Health News:New center to lead international muscular dystrophy research effort 4Health News:Blood Pressure Drug Might Work Against Alzheimer's 2Health News:SXC Health Solutions to Host Fiscal 2007 Third Quarter Financial Results Conference Call 2
(Date:11/9/2009)...swire/ -- AMD LASERS just announced that industry ...accepted the position of Medical Director. In his...eeing research and development of new soft and har...or continuing education credits, authoring article... and lecturing and seminar engagements. ,, "We ...
(Date:11/9/2009)...Newswire/ -- Access MediQuip, LLC, the nation,s fi... medical device management solutions to the health...ng its corporate headquarters to Lake Mary, Florid...id growth, includes a major expansion of the Prime...January 2010 and relocation and expansion of the H...
(Date:11/9/2009)...RNewswire/ -- Thomson Reuters today announced th...a leading clinical surveillance solution that enab...-time and respond immediately to improve clinical ...This upgrade is available to current CareFocus cus...0 contains several powerful enhancements that impr...
Breaking Medicine Technology:AMD LASERS Names Dr. James Jesse as Medical Director 2Access MediQuip Moves Company Headquarters to Lake Mary, Florida 2Thomson Reuters Clinical Surveillance Solution Offers Powerful New Functionality to Improve Clinical Quality and Reduce Costs 2Thomson Reuters Clinical Surveillance Solution Offers Powerful New Functionality to Improve Clinical Quality and Reduce Costs 3Test Before Corneal Transplant May Improve Outcome 50548 1Test Before Corneal Transplant May Improve Outcome 50548 2Everock Inc Completes Reverse Merger with Privately Held All Natural Food Producer Natures Peak 50545 1Everock Inc Completes Reverse Merger with Privately Held All Natural Food Producer Natures Peak 50545 2Everock Inc Completes Reverse Merger with Privately Held All Natural Food Producer Natures Peak 50545 3Biocept Inc Announces Two New Director Appointments 12871 1Biocept Inc Announces Two New Director Appointments 12871 2
...WIRE)--May 23, 2007 - Synta,Pharmaceuticals Corp.,...d on discovering, developing, and commercializing ...tions, today announced,that survival and sub-popul...astatic melanoma of the Company,s lead oncology dr...nnual meeting of the,American Society of Clinical ...
...armaceutical Co, Ltd. Sponsored Study,Presented at...ng -, SAN DIEGO, May 23, 2007 /PRNewswire/ -- In a...with schizophrenia, the Otsuka,Pharmaceutical Co.,...tipsychotic aripiprazole demonstrated significant ...icacy endpoint, Positive and,Negative Syndrome Sca...
Other Medicine Technology:Synta Oncology Candidate STA-4783 Clinical Trial Results to Be,Presented at the ASCO Annual Meeting 2Synta Oncology Candidate STA-4783 Clinical Trial Results to Be,Presented at the ASCO Annual Meeting 3Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 2Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 3Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 4Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 5Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 6Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 7Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 8Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 9
CHECK-FLO Performer Introducer Sets For Radial Artery Access
Extra Large Check-Flo Introducers
KELLER-TIMMERMANS INTRODUCER SETS
SHUTTLE-SL FLEXOR TUOHY-BORST Side-Arm Introducer Sets
Medicine Products: